Goldman Sachs fumbles $143m Telix block trade, infuriating investors

The Australian Financial Review
03-02

What’s a good time to launch a block trade? According to Goldman Sachs’ equity capital markets team, the answer appears to be 11pm on a Thursday, and hours after a similarly sized sell-down at the same company.

That’s when the Wall Street investment banking giant decided to sell 1.5 per cent of Telix Pharmaceuticals, a Melbourne radiopharmaceuticals specialist with a market capitalisation of more than $9.5 billion, on behalf of China’s Grand Pharma. The next day, thanks to the ill-timed block trade, shares fell 6.3 per cent, wiping half a billion dollars from the company’s valuation.

Loading...

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10